Belgium Unveils New Leniency Guidelines
Client Alert | 1 min read | 10.24.07
CompetitionLaw360
Belgium has revealed a new set of guidelines for its leniency program, hoping to better employ the competition tool that has enabled U.S., EU and Asian antitrust authorities to unravel some of the world’s most notorious cartels. Belgium published a revamped version of its 2004 leniency initiative in the Belgium State Gazette, indicating a desire to keep up with the strides and various refinements that have been made to such programs over the years.
Under the new legislation, Belgium will reportedly accept oral leniency and implement a marker system, an increasingly popular feature among immunity programs. The acceptance of oral or other nonwritten statements from cartel members applying for leniency will help to protect companies concerned about producing hard documents that could later be subpoenaed or discoverable in civil litigation elsewhere, especially in the U.S. The marker system would enable cartel members to come forward and reserve places in line for leniency even before they have gathered information. This, regulators believe, will help them to capitalize on cartel members’ distrustful paranoia and ensure that members would come forward quickly.
Though the council has received an estimated 20 immunity applications since the program was first introduced in 2004, most of those were the result of companies applying for leniency in several jurisdictions, also known as double-dips. Seeking to toughen up the program, the council began the process of revising its leniency program back in September, inviting practitioners to comment on the process for the first time ever.
Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 1 min read | 04.17.26
Client Alert | 3 min read | 04.17.26
Client Alert | 2 min read | 04.16.26
